DALLAS--(BUSINESS WIRE)--
Jacobs
Engineering Group Inc. (NYSE:JEC) received an engineering,
procurement, construction management and validation (EPCmV) services
contract for the new Ferring
Pharmaceuticals research and development (R&D) headquarters, which
will be located in Copenhagen, Denmark. Jacobs was selected for this
project phase following the successful completion of the conceptual
study and basic engineering design.
As Ferring Pharmaceuticals’ principal biopharmaceutical product
development center, this new facility will feature collaborative work
spaces and serve as an inspirational, global Research & Development unit
for identifying and developing innovative products in the fields of
reproductive health, urology, gastroenterology, endocrinology and
orthopedics.
When constructed, the facility will include six stories above grade, two
basement levels, and a site area of approximately 124,000 square feet
(11,500 square meters). Jacobs is working alongside Foster
+ Partners, an architecture consultancy firm, to develop the iconic
vision for the new R&D center.
“Our clients turn to Jacobs because we provide the biopharmaceutical
labs and corporate building expertise they need, as well as end-to-end
solutions for delivering their facility to completion,” said Jacobs
Buildings & Infrastructure and Industrial President Bob Pragada.
Jacobs is one of the world’s largest and most diverse providers of
full-spectrum technical, professional and construction services for
industrial, commercial and government organizations globally. The
company employs over 54,000 people and operates in more than 25
countries around the world. For more information, visit www.jacobs.com.
Statements made in this release that are not based on historical fact
are forward-looking statements. We base these forward-looking statements
on management’s current estimates and expectations as well as currently
available competitive, financial and economic data. Forward-looking
statements, however, are inherently uncertain. There are a variety of
factors that could cause business results to differ materially from our
forward-looking statements. For a description of some of the factors
which may occur that could cause actual results to differ from our
forward-looking statements please refer to our Form 10-K for the year
ended September 30, 2016, and in particular the discussions contained
under Items 1 - Business, 1A - Risk Factors, 3 - Legal Proceedings, and
7 - Management's Discussion and Analysis of Financial Condition and
Results of Operations. We do not undertake to update any forward-looking
statements made herein.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170927005305/en/
Source: Jacobs Engineering Group Inc.